Oscar Health, Inc.
NYSE:OSCR
14 (USD) • At close July 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Revenue
| 9,177.941 | 5,862.869 | 4,125.584 | 1,920.961 | 589.641 | 553.779 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 9,177.941 | 5,862.869 | 4,125.584 | 1,920.961 | 589.641 | 553.779 |
| Gross Profit Ratio
| 1 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 1,755.942 | 1,424.763 | 1,419.37 | 265.078 | 166.655 | 110.682 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1,755.942 | 1,424.763 | 1,419.37 | 265.078 | 166.655 | 110.682 |
| Other Expenses
| 7,388.573 | 4,705.406 | 3,316.289 | 2,226.463 | 828.766 | 702.486 |
| Operating Expenses
| 9,144.515 | 6,130.169 | 4,735.659 | 2,491.541 | 995.421 | 813.168 |
| Operating Income
| 33.426 | -267.3 | -610.075 | -570.58 | -405.78 | -259.389 |
| Operating Income Ratio
| 0.004 | -0.046 | -0.148 | -0.297 | -0.688 | -0.468 |
| Total Other Income Expenses Net
| 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax
| 33.426 | -267.3 | -610.075 | -570.58 | -405.78 | -259.389 |
| Income Before Tax Ratio
| 0.004 | -0.046 | -0.148 | -0.297 | -0.688 | -0.468 |
| Income Tax Expense
| 7.305 | 3.294 | -0.523 | 0.846 | 1.045 | 1.793 |
| Net Income
| 25.432 | -270.728 | -606.275 | -572.606 | -406.825 | -261.182 |
| Net Income Ratio
| 0.003 | -0.046 | -0.147 | -0.298 | -0.69 | -0.472 |
| EPS
| 0.11 | -1.22 | -2.87 | -3.19 | -1.7 | -8.93 |
| EPS Diluted
| 0.096 | -1.22 | -2.87 | -3.19 | -1.7 | -1.09 |
| EBITDA
| 89.305 | -212.003 | -572.169 | -551.255 | -390.981 | -252.49 |
| EBITDA Ratio
| 0.01 | -0.036 | -0.139 | -0.287 | -0.663 | -0.456 |